Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved published : Yesterday save search
Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
Published: 2024-04-19 (Crawled : 14:00) - biospace.com/
SBFM | $1.84 -44.58% 9M
|
Professional, Scientific, and T...
|
| O: -65.59%
H: 0.0%
C: 0.0%
pharma biosimilar health approval for canada
Health Canada Approves KEYTRUDA as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma
Published: 2024-04-19 (Crawled : 13:00) - biospace.com/
MRK | $125.8 0.46% 3.4M
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
health treatment for canada advanced keytruda
Todays' Top-5
ContextLogic Announces Stockholder Approval of Transaction with Qoo10
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
WISH | $5.85 1.92% 1.2M
|
|
| O: 16.96%
H: 0.0%
C: 0.0%
approval
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
Published: 2024-04-19 (Crawled : 10:00) - globenewswire.com
ALVO | $13.455 4.38% 1.6M
|
n/a
|
| O: 4.19%
H: 0.0%
C: 0.0%
KMDA | $5.21 2.16% 19K
|
Health Technology
|
| O: 1.76%
H: 0.0%
C: 0.0%
humira biosimilar approved for agreement
NeoGames and Aristocrat Receive Final Regulatory Approvals on Proposed Acquisition
Published: 2024-04-18 (Crawled : 23:00) - globenewswire.com
NGMS | News | $29.45 0.14% 570K
|
Technology Services
| Email alert
Add to watchlist
acquisition
U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
Published: 2024-04-18 (Crawled : 23:00) - biospace.com/
TAK | News | $13.185 0.19% 430K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
entyvio fda disease active for therapy
California Water Service Group Moving Forward to Install PFAS Treatment Despite CPUC Dismissal of Request to Track Capital Costs in Pre-Approved Memorandum Account
Published: 2024-04-18 (Crawled : 21:00) - globenewswire.com
CWT | News | $45.53 1.4% 91K
|
Utilities
| Email alert
Add to watchlist
water california service group treatment
Glacier Bancorp, Inc. Receives Regulatory Approval for Acquisition of Six Montana Branches From HTLF Bank
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
GBCI | News | $36.27 3.33% 370K
|
Finance
| Email alert
Add to watchlist
HTLF | News | $34.48 2.99% 83K
|
Finance
| Email alert
Add to watchlist
FRBA | News | $12.41 2.39% 23K
|
Finance
| Email alert
Add to watchlist
six approval acquisition for
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-18 (Crawled : 18:00) - biospace.com/
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
XOMA | News | $25.57 3.98% 4.1K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
biopharma platform
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch
Published: 2024-04-18 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
fda biosimilar approval for stelara
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
AULT | $0.2998 23.83% 53M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.